BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹63.55
- Market cap
- ₹83.73 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 40.8×Sector 45.9×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Concord Drugs Board Meeting Date
Concord Drugs Limited scheduled a board meeting on August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Greenleaf Envirotech Other Announcement
Greenleaf Envirotech reported no deviation in IPO and warrant fund use for the half-year to September 2026. Statutory auditors certified the utilisation of the funds.
Ashram Online.com Other Announcement
Ashram Online.Com Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. This routine regulatory disclosure reports no transaction, money or business event.
Tolins Tyres Other Announcement
Tolins Tyres filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Promoter and promoter group hold about 68.53 percent of equity.
Sacheerome Other Announcement
Sacheerome reported no deviation in IPO fund utilisation for the half year ended 30 September 2026. The filing is a routine Reg 32 proceeds statement.
Yaan Enterprises Other Announcement
Yaan Enterprises filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Promoter and promoter group hold 70.65% of the 31,00,000 share capital.
Zen Technologies Other Announcement
Zen Technologies reported no QIP fund utilisation deviation for the quarter ended September 30, 2026. Rs.737.85 Crore of Rs.979.51 Crore raised is utilised per original objects.